Aspen Neuroscience

Aspen Neuroscience is a development stage and private biotechnology company that uses innovative genomic approaches combined with stem cell biology to deliver patient-specific, restorative cell therapies that modify the course of Parkinson's disease. It is developing induced-pluripotent stem cells (iPSCs) to address diseases with high unmet medical needs, beginning with autologous neuron replacement for both sporadic and genetic forms of Parkinson's disease (PD) and extending across the brain and affected organs.

Aspen Neuroscience headquartered in United States, North America, operates in the Biotechnology, Pharmaceutical, Medical, Therapeutics sector. The company focuses on Biotechnology and has secured $21.8B in funding across 80 round(s). With a team of 51-100 employees, Aspen Neuroscience is actively contributing to advancements in Biotechnology. Their latest funding round, Grant - Aspen Neuroscience, raised $8.0M. Discover more about their projects, partnerships, and impact on our platform.